ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/06/23 | 1,189 | 1,254 | 1,178 | 1,236 | +55 | +4.7% | 645,600 |
| 2022/06/22 | 1,239 | 1,240 | 1,170 | 1,181 | -39 | -3.2% | 415,900 |
| 2022/06/21 | 1,185 | 1,235 | 1,178 | 1,220 | +59 | +5.1% | 559,500 |
| 2022/06/20 | 1,170 | 1,206 | 1,146 | 1,161 | +12 | +1% | 369,100 |
| 2022/06/17 | 1,121 | 1,160 | 1,117 | 1,149 | -15 | -1.3% | 573,300 |
| 2022/06/16 | 1,206 | 1,207 | 1,163 | 1,164 | -17 | -1.4% | 309,600 |
| 2022/06/15 | 1,171 | 1,184 | 1,149 | 1,181 | +12 | +1% | 346,900 |
| 2022/06/14 | 1,168 | 1,178 | 1,136 | 1,169 | -26 | -2.2% | 527,200 |
| 2022/06/13 | 1,171 | 1,195 | 1,151 | 1,195 | -1 | -0.1% | 586,700 |
| 2022/06/10 | 1,224 | 1,229 | 1,192 | 1,196 | -58 | -4.6% | 577,900 |
| 2022/06/09 | 1,208 | 1,266 | 1,202 | 1,254 | +47 | +3.9% | 490,400 |
| 2022/06/08 | 1,185 | 1,215 | 1,180 | 1,207 | +39 | +3.3% | 405,400 |
| 2022/06/07 | 1,215 | 1,215 | 1,168 | 1,168 | -50 | -4.1% | 422,800 |
| 2022/06/06 | 1,196 | 1,231 | 1,189 | 1,218 | +21 | +1.8% | 365,100 |
| 2022/06/03 | 1,208 | 1,216 | 1,183 | 1,197 | +13 | +1.1% | 427,000 |
| 2022/06/02 | 1,199 | 1,203 | 1,174 | 1,184 | -27 | -2.2% | 393,000 |
| 2022/06/01 | 1,231 | 1,255 | 1,211 | 1,211 | -28 | -2.3% | 354,300 |
| 2022/05/31 | 1,274 | 1,276 | 1,239 | 1,239 | -33 | -2.6% | 418,900 |
| 2022/05/30 | 1,254 | 1,284 | 1,250 | 1,272 | +37 | +3% | 601,000 |
| 2022/05/27 | 1,231 | 1,241 | 1,205 | 1,235 | +13 | +1.1% | 569,000 |
| 2022/05/26 | 1,181 | 1,236 | 1,179 | 1,222 | +57 | +4.9% | 665,700 |
| 2022/05/25 | 1,199 | 1,207 | 1,161 | 1,165 | -35 | -2.9% | 474,100 |
| 2022/05/24 | 1,168 | 1,218 | 1,160 | 1,200 | +18 | +1.5% | 597,000 |
| 2022/05/23 | 1,220 | 1,228 | 1,168 | 1,182 | -28 | -2.3% | 892,200 |
| 2022/05/20 | 1,149 | 1,225 | 1,141 | 1,210 | +78 | +6.9% | 880,500 |
| 2022/05/19 | 1,065 | 1,137 | 1,062 | 1,132 | +14 | +1.3% | 650,000 |
| 2022/05/18 | 1,091 | 1,141 | 1,080 | 1,118 | +49 | +4.6% | 867,800 |
| 2022/05/17 | 1,053 | 1,123 | 1,031 | 1,069 | +51 | +5% | 992,500 |
| 2022/05/16 | 1,030 | 1,034 | 1,001 | 1,018 | +4 | +0.4% | 482,700 |
| 2022/05/13 | 1,020 | 1,044 | 1,011 | 1,014 | +17 | +1.7% | 605,100 |
| 2022/05/12 | 1,022 | 1,028 | 997 | 997 | -55 | -5.2% | 721,300 |
| 2022/05/11 | 1,046 | 1,065 | 1,012 | 1,052 | +8 | +0.8% | 571,800 |
| 2022/05/10 | 1,038 | 1,052 | 1,018 | 1,044 | -11 | -1% | 645,500 |
| 2022/05/09 | 1,088 | 1,102 | 1,051 | 1,055 | -53 | -4.8% | 648,500 |
| 2022/05/06 | 1,140 | 1,140 | 1,102 | 1,108 | -41 | -3.6% | 535,700 |
| 2022/05/02 | 1,145 | 1,160 | 1,130 | 1,149 | -1 | -0.1% | 266,900 |
| 2022/04/28 | 1,156 | 1,181 | 1,141 | 1,150 | -6 | -0.5% | 333,300 |
| 2022/04/27 | 1,156 | 1,165 | 1,135 | 1,156 | -40 | -3.3% | 526,600 |
| 2022/04/26 | 1,207 | 1,213 | 1,180 | 1,196 | +5 | +0.4% | 331,400 |
| 2022/04/25 | 1,195 | 1,215 | 1,179 | 1,191 | -30 | -2.5% | 638,900 |
| 2022/04/22 | 1,227 | 1,240 | 1,206 | 1,221 | -33 | -2.6% | 469,900 |
| 2022/04/21 | 1,288 | 1,300 | 1,251 | 1,254 | -34 | -2.6% | 474,800 |
| 2022/04/20 | 1,315 | 1,317 | 1,281 | 1,288 | -12 | -0.9% | 264,200 |
| 2022/04/19 | 1,315 | 1,319 | 1,294 | 1,300 | -5 | -0.4% | 226,000 |
| 2022/04/18 | 1,294 | 1,318 | 1,291 | 1,305 | ±0 | ±0% | 288,900 |
| 2022/04/15 | 1,315 | 1,338 | 1,287 | 1,305 | -27 | -2% | 463,900 |
| 2022/04/14 | 1,313 | 1,344 | 1,293 | 1,332 | +32 | +2.5% | 452,500 |
| 2022/04/13 | 1,301 | 1,329 | 1,297 | 1,300 | +6 | +0.5% | 475,400 |
| 2022/04/12 | 1,294 | 1,312 | 1,264 | 1,294 | -30 | -2.3% | 472,100 |
| 2022/04/11 | 1,331 | 1,339 | 1,291 | 1,324 | -22 | -1.6% | 424,900 |
701～
750
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 241,500円 | +21.7% | +999.9% | 0.00% | 10.06倍 | 3.33倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 東和薬品 | 263,700円 | +15.0% | -7.3% | 2.65% | 8.65倍 | 0.82倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 234,300円 | +14.2% | +41.0% | 1.96% | 11.48倍 | 1.17倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 持田薬 | 309,000円 | +3.0% | +27.5% | 2.59% | 19.56倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 148,600円 | +8.8% | +99.9% | 3.50% | 9.49倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
